Apogee Therapeutics (APGE) Fundamental Analysis: Revenue, Earnings & Valuation

3.58 / 10

Netural

With a 3.6/10 fundamental rating, the stock demonstrates poor characteristics. Strengths in Asset-MV and Cash-MV, though challenges appear in Current assets turnover ratio and Gross profit margin (%). suggest selective potential.

Analysis Checks(7/10)

Revenue-MV

Value-0.18

Score1/3

Weight12.05%

1M Return6.44%

Total operating revenue (YoY growth rate %)

Value142.01

Score3/3

Weight2.17%

1M Return1.39%

Inventory turnover ratio

Value98.00

Score3/3

Weight17.51%

1M Return9.22%

Gross profit margin (%)

Value35.30

Score1/3

Weight-1.82%

1M Return-1.32%

Income tax / Total profit (%)

Value-0.11

Score2/3

Weight0.50%

1M Return0.32%

Current assets turnover ratio

Value2.32

Score1/3

Weight0.30%

1M Return0.21%

Cost of sales ratio (%)

Value71.88

Score3/3

Weight6.25%

1M Return3.85%

Asset-MV

Value-0.49

Score2/3

Weight45.63%

1M Return20.76%

Cash-MV

Value0.01

Score2/3

Weight15.09%

1M Return7.94%

Net profit / Total profit (%)

Value100.11

Score2/3

Weight2.31%

1M Return1.44%

Is APGE undervalued or overvalued?

APGE scores 3.58/10 on fundamentals and holds a Fair valuation at present. Backed by its -31.57% ROE, 0.00% net margin, -24.49 P/E ratio, 6.93 P/B ratio, and -27.88% earnings growth, these metrics solidify its Netural investment rating.